HERON THERAPEUTICS, INC. /DE/ Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q1 2017 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q1 2017 to Q1 2024.
  • Heron Therapeutics, Inc. /De/ Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2024 was $649K.
  • Heron Therapeutics, Inc. /De/ annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $3.06M, a 36% increase from 2022.
  • Heron Therapeutics, Inc. /De/ annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $2.25M, a 80.9% increase from 2021.
  • Heron Therapeutics, Inc. /De/ annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $1.24M.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $649K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2018 $500K -$500K -50% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $1M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.